Juvenile Idiopathic Arthritis

Types of Arthritis

ILAR Classification of JIA

DNB 1996, 2006, 2008, 2010, 2011, 2012, 2013, 2015, 2021, 2023

  1. Classification of JRA
  2. Types of JRA / JIA
  3. Diagnostic criteria for JIA
  4. ILAR classification

type criteria
Systemic JIA - arthritis of more than 2 weeks (documented for atleast 3 days)
- 1 or more of
- HSM
- Evanascent rash
- Lymphadenitis
- serositis
Oligo JIA - involving four of less joints in the first 6 months of disease
- Extended oligoarthritis - involving more than 4 joints after 6 months of disease
- persistent oligoarthritis - involving only 4 or less joints even after 6 months of disease
RF + poly JIA - involvement of five of more joints in the first 6 months of disease
- RF positive (2 tests 3 months apart)
RF - poly JIA - involvement of five of more joints in the first 6 months of disease
- RF negative
Psoriatic - arthritis with psoriasis
- arthritis with 2 or more of
- nail pitting
- dactylitis
- psoriasis in 1 degree relative
ERA - enthesitis with arthritis
- enthesitis or arthritis only with 2 or more of
- lumbosacral tenderness or inflammatory sacroiliac pain
- acute symptomatic anterior uveitis
- HLA b27+
- onset in male > 6 years
- history of ankylosing spondylitis, reiters, ERA in 1st degree relative
Undifferentiated arthritis that fulfils none of more than 2 of the above

Patterns

oligo JIA

poly JIA

ERA

systemic

psoriatic

RF + vs RF -

RF +

RF -

Differential Diagnosis

DNB 2004, 2011, 2013, 2014, 2015, 2023

Differential diagnosis of child with swelling for more than 6 weeks

single joint involvement

multiple joint involvement

systemic features

non-inflammatory

Investigations

DNB 2011 DCH 2024

Investigation of JIA
Primarily Clinical diagnosis

radiology

Management

DNB 2006, 2010, 2012, 2014, 2018 DCH 2024

  1. Management of JIA
  2. principle of treatment of JIA

Drugs used

  1. NSAIDS
    • Naproxen
  2. DMARDs
    • Conventional
      • Methotrexate
      • Leflunomide
    • Non conventional (biologicals)
      • Anti TNF alpha
        • eternacept
        • adalimumab
      • JAK inhibitors
        • Tofacitinib
        • Ruxolitinib
  3. Corticosteroids
    • adjuvent
    • triamcinolone
    • bridge therapy
  4. Physical / occupational therapy

Principle of treatment

ERA

oligo JIA

poly JIA

systemic JIA

Periodic slitt lamp evalution for uveitis must be done in all children

drugs used in JIA

DNB 2014, 2023

Drugs used in JIA

Drugs in JIA

Neslon screenshot

TB screening for biologicals